课题基金 / 基金详情

C. ELEGANS MODEL FOR POLYGLUTAMINE TOXICITY

C. ELEGANS MODEL FOR POLYGLUTAMINE TOXICITY
C. 多聚谷氨酰胺毒性的线虫模型
批准号:
6822583
负责人:
Anne Church Hart
金额:
$34.6万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-12-15 至 2006-11-30

项目摘要

项目成果

Anne Church Hart的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (From the Applicant's Abstract): Eight neurodegenerative diseases are caused by expansion of glutamine tracts in proteins, including spinal cerebellar ataxias, DRPLA, Huntington's disease and Kennedy's disease. It is unclear why expanded polyglutamine tracts are toxic and there is no treatment for these diseases. We have developed a C. elegans overexpression model for polyglutamine neurotoxicity by expressing huntingtin protein fragments in neurons and we will assess the toxic activity of mutant ataxin-1 and ataxin-3 in these same C. elegans neurons. Mutation of pqe-1 specifically and strongly enhances polyQ toxicity in C. elegans. We will clone and characterize pqe-1. We will characterize and clone additional enhancer genes and will identify, characterize and clone suppressor genes. The corresponding proteins are candidate modifiers of polyglutamines toxicity in Huntington's and other polyglutamine diseases. We will generate mutations in C. elegans homologs of huntintin, ataxin-1 and ataxin-3 to address their role in the nervous system and in neurodegeneration. The relationship between these genes, polyglutamine toxicity, the apoptotic pathway and other candidate genes will be assessed. We will identify human homologs of enhancer and suppressor genes identified in our genetic screens and assess their role in polyglutamine toxicity in other model organisms to address the relevance of these candidate genes to human disease.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Caenorhabditis elegans as a model system for triplet repeat diseases.
秀丽隐杆线虫作为三联体重复疾病的模型系统。
DOI: 10.1385/1-59259-804-8:141
发表时间: 2004
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Voisine,Cindy, Hart,AnneC]
通讯作者: Hart,AnneC
DOI: 10.1016/j.nbd.2010.05.012
发表时间: 2010-10
期刊: Neurobiology of disease
影响因子: 6.1
作者: [Dimitriadi M, Hart AC]
通讯作者: Hart AC
Examining cross-species suppression of neurodegeneration by loss of a conserved RNA binding protein in models of ALS and FTD
  • 批准号:
    10195707
  • 项目类别:
  • 资助金额:
    $41.65万
  • 财政年份:
    2021
  • 负责人:
    Anne Church Hart
  • 依托单位:
Notch Functions in the Adult Nervous System
  • 批准号:
    8078195
  • 项目类别:
  • 资助金额:
    $31.26万
  • 财政年份:
    2009
  • 负责人:
    Anne Church Hart
  • 依托单位:
Notch Functions in the Adult Nervous System
  • 批准号:
    7654805
  • 项目类别:
  • 资助金额:
    $5.59万
  • 财政年份:
    2009
  • 负责人:
    Anne Church Hart
  • 依托单位:
Notch Functions in the Adult Nervous System
  • 批准号:
    8010052
  • 项目类别:
  • 资助金额:
    $29.19万
  • 财政年份:
    2009
  • 负责人:
    Anne Church Hart
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: